@prefix nt: .
@prefix this: .
@prefix sub: .
@prefix drugbank: .
@prefix np: .
@prefix mondo: .
@prefix pav: .
@prefix infores: .
@prefix xsd: .
@prefix orcid: .
@prefix rdfs: .
@prefix pmid: .
@prefix ncit: .
@prefix rdf: .
@prefix biolink: .
@prefix prov: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
drugbank:DB01238 a biolink:Drug;
rdfs:label "Aripiprazole";
biolink:category biolink:Drug .
mondo:0001156 a biolink:Disease;
rdfs:label "Borderline personality disorder (disease)";
biolink:category biolink:Disease .
sub:association a biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
rdf:object mondo:0001156;
rdf:predicate biolink:treats;
rdf:subject drugbank:DB01238;
rdfs:label "The SGA olanzapine is considered the most appropriate, followed by quetiapine and aripiprazole. Although off-label prescription of SGAs represents a common clinical practice in accordance with a worldwide trend, the use of long-acting injection formulations was considered inappropriate by 69% of psychiatrists in our sample. Attitudes on off-label use of Aripiprazole in the treatment of BPD: Highly inappropriate = 44 (21.8%); Innapropriate = 38 (18.8%); Doubt = 74 (36.6%); Appropriate = 43 (21.3%); Highly appropriate = 3 (1.5%)";
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
biolink:has_population_context sub:context;
biolink:publications pmid:31609189;
biolink:relation ncit:C94303 .
sub:context a biolink:Cohort;
rdfs:label "Adults";
biolink:category biolink:Cohort .
}
sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB";
npx:hasSignature "HHE32MFhZ+X3Iy6ONN2B55efujcfcc702BCBaxojSJLxHxUUivbPjJ2wm0vo9dk2El/aVOBYmm9tksNyQD4wnKMTnkQoAk3hizQxRm44LD7Nn8u+SGwjpLaxerCkUmlV3RY8Mc5OO7EV35RMMfY/4KhSb98HUR/58vhQoG2TTzo=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2022-09-16T11:49:14.276487"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-1501-1082;
nt:wasCreatedFromTemplate .
biolink: pav:version "2.3.0" .
}